关于此课程： Current and future public health is characterized by the increase of chronic and degenerative diseases, corresponding to the worldwide ageing of the population. The increasing prevalence of these conditions together with the long incubation period of the chronic diseases and the continual technological innovations, offer new opportunities to develop strategies for early diagnosis. Public Health has an important mandate to critically assess the promises and the pitfalls of disease screening strategies. This MOOC will help you understand important concepts for screening programs that will be explored through a series of examples that are the most relevant to public health today. We will conclude with expert interviews that explore future topics that will be important for screening. By the end of this MOOC, students should have the competency needed to be involved in the scientific field of screening, and understand the public health perspective in screening programs. This MOOC has been designed by the University of Geneva and the University of Lausanne. This MOOC has been prepared under the auspices of the Ecole romande de santé publique (www.ersp.ch) by Prof. Fred Paccaud, MD, MSc, Head of the Institute of Social and Preventive Medicine in Lausanne (www.iumsp.ch), in collaboration with Professor Antoine Flahault, MD, PhD, head of the Institute of Global Health, Geneva (https://www.unige.ch/medecine/isg/en/) and Prof. Gillian Bartlett-Esquilant (McGill University, Quebec/ Institute of Social and Preventive Medicine, Lausanne).
制作方： University of Geneva, University of Lausanne
教学方： Antoine Flahault, Professor of Public Health and Director of the Institute of Global Health (Faculty of Medicine, University of Geneva) and co-Director of Centre Virchow-Villermé (Université Paris Descartes)
University of Geneva and Université Paris Descartes – Sorbonne Paris Cité教学方： Fred Paccaud (In Partnership with UNIGE), Professor of epidemiology and public health and Director of the Institute of social and preventive medicine
Lausanne University Hospital教学方： Gillian Bartlett-Esquilant, Professor of Epidemiology and Research and Graduate Program Director and Associate Chair for the Department of Family Medicine at McGill University.
University of Lausannne and McGill University
| 级别 | 初级 |
| 承诺学习时间 | 7 weeks of study, 1-3 hours/week |
| 语言 | English |
| 如何通过 | 通过所有计分作业以完成课程。 |
| 用户评分 |
授课大纲
第 1 周
Introduction to Key Concepts in Screening
This module will provide a brief welcome by Dr. Fred Paccaud and Dr. Antoine Flahault. An overview of screening and an introduction on how the course is organized and evaluated will be provided by Dr. Gillian Bartlett-Esquilant. Dr. Idris Guessous, a Senior Lecturer in the Population Epidemiology Unit in the Department of Community Medicine, Primary Care and Emergency Medicine (Geneva), and in the Department of Ambulatory Care and Community Medicine (PMU Lausanne) & Division of Chronic Diseases at the Institute of Social and Preventive Medicine (Lausanne) will provide lectures on definitions of screening. Natural history of diseases and the characteristics of subclinical conditions allowing early diagnosis will be presented. A quiz on the key concepts for screening will complete this module.
9 个视频, 9 个阅读材料
- Reading: Course Instructors
- Reading: Development Team
- Reading: Course Description: Modules & Themes
- Reading: Course design
- Reading: Grading policy
- Reading: Discussion Forum Guidelines
- Reading: Getting started: Break the ice !
- 视频: Definition of Screening
- 视频: Definition of a Screening Program
- 视频: Natural History of Diseases
- 视频: Lead Time, Diagnosis and Treatment
- 视频: Risk of Overdiagnosis
- 视频: Screening Tests and Biomarkers
- 视频: The Prevention Paradox
- 视频: Target Populations for Screening
- Reading: Suggested discussion
- Reading: Reading List for Concepts
已评分: Introduction to Key Concepts in Screening
第 2 周
Screening Metrics
The second module, provided by Dr. Idris Guessous, will address the metrics of screening with concepts related to robustness, validity and impact. A quiz on screening metrics will complete this module.
10 个视频, 2 个阅读材料
- 视频: Robustness of Tests
- 视频: Validity
- 视频: Sensitivity and Specificity
- 视频: Predictive Values
- 视频: Outcomes and Study Design
- 视频: Number Needed to Screen
- 视频: Presentation of the 2-by-2 Table
- 视频: Ethics
- 视频: Shared Decison Making_ new video
- Reading: Suggested discussion
- Reading: Metrics
已评分: Screening Metrics
第 3 周
Screening in Pregnancy and Newborns
This module on screening in the prenatal (pregnancy) and perinatal (newborn) stage of life is given by Professor Murielle Bochud, MD, PhD, head of the Institute of social and preventive medicine in Lausanne, Switzerland. A quiz will complete this module.
6 个视频, 3 个阅读材料
- 视频: Key Concepts for Genetic Screening Tests
- 视频: Overview of Prenatal and Perinatal Screening
- 视频: Example of an Improved Screening Test: Down Syndrome
- 视频: Example of Screening to Improve Prognosis: Congenital Hearing Loss
- 视频: Example of Genetic Screening: Cystic Fibrosis
- Reading: Suggested discussion
- Reading: Genetic conditions
- Reading: Prenatal and perinatal conditions
已评分: Screening in Pregnancy and Newborns
第 4 周
Screening for Cardiometabolic Conditions
Senior lecturer Arnaud Chiolero, MD, PhD, from the Division of Chronic Diseases at the Institute of Social and Preventive Medicine in Lausanne will be presenting three case studies related to the increasingly prevalent condition of cardiometabolic disease. Three different diseases will be explored in terms of burden of disease, benefits and harms, evidence and issues followed by recommendations about whether screening should be implemented. A quiz will complete this module.
4 个视频, 2 个阅读材料
- 视频: Case 1: Hypertension
- 视频: Case 2: Diabetes
- 视频: Case 3: Cardiovascular Risk Factors in Children
- Reading: Suggested discussion
- Reading: Cardiometabolic conditions
已评分: Screening for Cardiometabolic Conditions
第 5 周
Cancer Screening
Cancer is a classical field for screening because of both the improvement of the prognosis for most cancers and the usually long incubation period. This part of the MOOC will present current data, evidence and policies regarding the most important cancer sites that include colorectum, prostate, lung, cervix, breast and skin. This module is given by several experts including Elisabetta Rapiti from the Geneva Cancer Registry at the Institute of Global Health in Geneva; Professor Antoine Flahault, who is the Head of the Institute of Global Health in Geneva; and Jean-Luc Buillard who is a Senior Lecturer in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. A quiz will complete this module.
8 个视频, 2 个阅读材料
- 视频: Colorectal Cancer
- 视频: Prostate Cancer
- 视频: Cervical Cancer
- 视频: Lung Cancer
- 视频: Skin_Cancer_Part I _new video
- 视频: Skin_Cancer_Part II_new video
- 视频: Breast_Cancer_new video
- Reading: Suggested discussion
- Reading: Cancer
已评分: Cancer Screening
第 6 周
Public Mental Health and Screening in Ageing
This module explores the topics of public mental health and screening in the ageing population for neuropsychiatric conditions and physical impairments such as hearing loss. This module is given by several experts including Emiliano Albanese, assistant professor in public mental health in the Department of Psychiatry at the University of Geneva and the Director of the WHO Collaborating Center for Research and Training in mental health at the University of Geneva; Professor Christophe Bula who is the head of the geriatric and geriatric rehabilitation service at the Vaudois University Hospital Centre; Professor Armin von Gunten who is the head of the university service for geriatric psychiatry at the Vaudois University Hospital Service. A quiz will complete this module.
6 个视频, 2 个阅读材料
- 视频: Introduction to Public Mental Health
- 视频: Public Mental Health and Disabilities
- 视频: Dementia and Related Disorders
- 视频: Old-Age Depression_new video
- 视频: General Screening in the Elderly_new video
- Reading: Suggested discussion
- Reading: Neuropsychiatric conditions
已评分: Public Mental Health and Screening in Ageing
第 7 周
Screening in Low and Middle-Income Countries and Migrants
The globalization of non-communicable diseases is a major challenge in low and middle income countries (LMIC). At the same time, migration is occurring between these countries and high income countries. Screening for cardiovascular diseases and for cancer in low and middle income countries will be presented and discussed. In addition, the special consideration of screening of migrants from these countries will be addressed. This module is given by: Professor Pascal Bovet from the Division of Chronic Diseases at the Institute of Social and Preventive Medicine in Lausanne; Dr. Catherine Sauvaget from the International Agency for Research on Cancer (IARC) in Lyon, France; and Professor Patrick Bodenmann from the Polimedical University Clinic and head of the Centre for Vulnerable Populations. A quiz will complete this module.
8 个视频, 3 个阅读材料
- 视频: Screening of Noncommunicable Disease in LMIC
- 视频: Optimal Strategy for Screening in LMIC
- 视频: Cardiovascular Disease (CVD) Screening in LMIC
- 视频: Focus on Hypertension for CVD Screening in LMIC
- 视频: Cancer Screening in LMIC
- 视频: Cross Cultural Competencies- Part I _new video
- 视频: Cross Cultural Competencies- Part II_new video
- Reading: Suggested discussion
- Reading: Screening in low and middle-income countries
- Reading: Screening of noncommunicable diseases in low and middle-income countries
已评分: Screening in Low and Middle-Income Countries and Migrants
第 8 周
Evaluation, Planning, Implementation and the Future of Screening Programs
In this final module, important aspects of for the evaluation, planning and decision making about the implementation or stopping of screening programs will be presented. This material is given by Senior lecturer Jean-Luc Bulliard who is an epidemiologist in the Division of Chronic Diseases at the Institute for Social and Preventive Medicine in Lausanne. The conclusion of the module will be a series of interviews with experts on the future of disease screening in public health conducted by Dr. Gillian Bartlett-Esquilant, a visiting professor at the Institute for Social and Preventive Medicine at Lausanne. A quiz will close this module.
9 个视频, 2 个阅读材料
- 视频: Major Controversies with Screening Programs
- 视频: Evaluation of Screening Programs
- 视频: Bias in Screening Programs
- 视频: Planning a Screening Program, Part I
- 视频: Planning a Screening Program, Part II
- 视频: Example of a Decision Aid for Screening
- 视频: Screening Program Implementation
- 视频: Future Directions in Screening Programs - Module 8 Conclusion_new video
- Reading: Suggested discussion
- Reading: Policies and evaluation
已评分: Evaluation, Planning, Implementation and the Future of Screening Programs
常见问题解答
运作方式
Coursework
Each course is like an interactive textbook, featuring pre-recorded videos, quizzes and projects.
Help from Your Peers
Connect with thousands of other learners and debate ideas, discuss course material, and get help mastering concepts.
Certificates
Earn official recognition for your work, and share your success with friends, colleagues, and employers.
制作方
University of Geneva
Founded in 1559, the University of Geneva (UNIGE) is one of Europe's leading universities. Devoted to research, education and dialogue, the UNIGE shares the international calling of its host city, Geneva, a centre of international and multicultural activities with a venerable cosmopolitan tradition.
University of Lausanne
The University of Lausanne is a Swiss state university founded in 1537. It is focused on Medicine, Life Sciences, Geosciences, Environmental Sciences, Business, Humanities, Social Sciences and Sport Sciences. UNIL is a research-intensive university which encourages interdisciplinarity. It is also renowned for its innovative teaching methods.
评分和审阅
Good but could have been even better if the speakers were more familiar with English pronounciation
First impression; very good! Have only started the first module
Very good, very useful and well done
km
1-What are the different study designs that may be used for evaluation of screening programs?
2-What are the important biases and controversies associated with screening?What are the different key resources needed for planning a screening program?What are the characteristics of the decision-making framework used for screening programs.?
3-What examples have you heard of or experienced for evaluation of screening programs?
4-Do you know any examples where screening programs have been stopped?In addition to the examples of future topics in public health screening, can you can think of other topics that would be important?
5- Can you describe how you see these topics developing in the future?
very informative program
thank you for your kind care